Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Beta Drugs Ltd

NSE: BETA · BSE: 531481 · Pharmaceuticals & Biotechnology · 27 announcements

Share price
₹1,991.00
Market cap
₹2,207 Cr
Revenue (annual)
₹384.8 Cr
Net profit (annual)
₹41.48 Cr
P/E (TTM)
48.4×Sector 47.4×
Promoter holding
59.10%-5.53% QoQ
FII holding
1.02%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

09:00 IST NSE
Regulatory Approval

Beta Drugs Regulatory Approval

Beta Drugs Limited achieved regulatory milestones in Azerbaijan and the Philippines. The company received generic drug approvals for two brands in the Philippines and successfully completed an Azerbaijan Ministry of Health inspection. These developments enhance access to CIS and Southeast Asian markets, supporting future export revenue growth.

Execution
Expected GMP approval in 1-2 months; further Philippines approvals in 6 months